
Kamada Ltd. KMDA
$ 7.83
-2.43%
Quarterly report 2025-Q4
added 05-06-2026
Kamada Ltd. DPO Ratio 2011-2026 | KMDA
Annual DPO Ratio Kamada Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 106 | 114 | 108 | 116 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 116 | 106 | 111 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
5.06 K | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 16.89 | -2.37 % | $ 789 M | ||
|
AgeX Therapeutics
AGE
|
5.24 K | - | -10.17 % | $ 12.2 K | ||
|
Compugen Ltd.
CGEN
|
82.7 | $ 2.85 | -5.94 % | $ 266 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Coherus BioSciences
CHRS
|
507 | $ 1.58 | -3.37 % | $ 185 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
Eton Pharmaceuticals
ETON
|
74.3 | $ 29.73 | -0.77 % | $ 800 M | ||
|
Exelixis
EXEL
|
148 | $ 50.09 | -1.98 % | $ 13.6 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Fortress Biotech
FBIO
|
400 | $ 2.47 | 7.39 % | $ 68.9 M | ||
|
Fennec Pharmaceuticals
FENC
|
894 | $ 9.51 | 2.92 % | $ 272 M | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.57 | -1.26 % | $ 418 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Gilead Sciences
GILD
|
45.3 | $ 129.56 | -1.9 % | $ 161 B | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
193 | $ 0.72 | -1.76 % | $ 32.9 M | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 3.13 | 0.32 % | $ 651 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 21.66 | 0.42 % | $ 2.76 B |